46. Sustained-Release Naltrexone for Opioid Dependence

  1. Iosief Abraha1 and
  2. Cristina Cusi2

Published Online: 13 AUG 2012

DOI: 10.1002/9781118454503.ch46

Alcohol and Drug Misuse

Alcohol and Drug Misuse

How to Cite

Abraha, I. and Cusi, C. (2012) Sustained-Release Naltrexone for Opioid Dependence, in Alcohol and Drug Misuse, John Wiley & Sons, Ltd, Chichester, UK. doi: 10.1002/9781118454503.ch46

Author Information

  1. 1

    Regional Health Authority of Umbria, Perugia, Italy

  2. 2

    Outpatient Services – Neurology, Clinical Institutes of Specialisation, Milan, Italy

Publication History

  1. Published Online: 13 AUG 2012
  2. Published Print: 7 AUG 2012

ISBN Information

Print ISBN: 9780470659694

Online ISBN: 9781118454503



  • sustained-release naltrexone for opioid dependence;
  • opioid dependence, chronic lifelong relapsing disorder;
  • methadone, currently effective in opioid dependence;
  • naltrexone opioid, effectively blocking heroin effects;
  • sustained-release naltrexone in opioid dependence, compared to placebo;
  • opioid use during/after treatment/adherence/induction/compliance;
  • other outcomes, illicit drugs/criminal acts affecting quality of life;
  • populations, adults/adolescents with opioid dependence;
  • sustained-release naltrexone on opioid dependence, insufficient;
  • naltrexone high drop-out, injections/implants as valid alternatives


This chapter contains sections titled:

  • Reference